|
1
|
Lee UE and Friedman SL: Mechanisms of
hepatic fibrogenesis. Best Pract Res Clin Gastroenterol.
25:195–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elpek GÖ: Cellular and molecular
mechanisms in the pathogenesis of liver fibrosis: An update. World
J Gastroenterol. 20:7260–7276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Seki E and Brenner DA: Recent advancement
of molecular mechanisms of liver fibrosis. J Hepatobiliary Pancreat
Sci. 22:512–518. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trautwein C, Friedman SL, Schuppan D and
Pinzani M: Hepatic fibrosis: Concept to treatment. J Hepatolo 62 (1
Suppl). S15–S24. 2015.
|
|
5
|
Friedman SL: Mechanisms of disease:
Mechanisms of hepatic fibrosis and therapeutic implications. Nat
Clin Pract Gastroenterol Hepatol. 1:98–105. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Coletta M, Nicolini D, Benedetti
Cacciaguerra A, Mazzocato S, Rossi R and Vivarelli M: Bridging
patients with hepatocellular cancer waiting for liver transplant:
All the patients are the same? Transl Gastroenterol Hepatol.
2:782017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Treiber T, Treiber N, Plessmann U,
Harlander S, Daiß JL, Eichner N, Lehmann G, Schall K, Urlaub H and
Meister G: A Compendium of RNA-binding proteins that regulate
MicroRNA biogenesis. Mol Cell. 66:270–284.e13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Fortin K and Mourelatos Z:
MicroRNAs: Biogenesis and molecular functions. Brain Pathol.
18:113–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murakami Y and Kawada N: MicroRNAs in
hepatic pathophysiology. Hepatol Res. 47:60–69. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Du J, Niu X, Fu N, Wang R, Zhang
Y, Zhao S, Sun D and Nan Y: MiR-130a-3p attenuates activation and
induces apoptosis of hepatic stellate cells in nonalcoholic
fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2.
Cell Death Dis. 8:e27922017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun J, Zhang H, Li L, Yu L and Fu L:
MicroRNA-9 limits hepatic fibrosis by suppressing the activation
and proliferation of hepatic stellate cells by directly targeting
MRP1/ABCC1. Oncol Rep. 37:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia
QM, Liu HM, He J, Yu HY and Zhu L: The rno-miR-34 family is
upregulated and targets ACSL1 in dimethylnitrosamine-induced
hepatic fibrosis in rats. FEBS J. 278:1522–1532. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu F, Lu Z, Chen B, Wu X, Dong P and Zheng
J: Salvianolic acid B-induced microRNA-152 inhibits liver fibrosis
by attenuating DNMT1-mediated Patched1 methylation. J Cell Mol Med.
19:2617–2632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng J, Yu F, Dong P, Wu L, Zhang Y, Hu Y
and Zheng L: Long non-coding RNA PVT1 activates hepatic stellate
cells through competitively binding microRNA-152. Oncotarget.
7:62886–62897. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin F, Wu X, Zhang H, You X, Zhang Z, Shao
R and Huang C: A microrna screen to identify regulators of
peritoneal fibrosis in a rat model of peritoneal dialysis. BMC
Nephrol. 16:482015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Renault MA, Roncalli J, Tongers J, Misener
S, Thorne T, Jujo K, Ito A, Clarke T, Fung C, Millay M, et al: The
Hedgehog transcription factor Gli3 modulates angiogenesis. Circ
Res. 105:818–826. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Syn WK, Jung Y, Omenetti A, Abdelmalek M,
Guy CD, Yang L, Wang J, Witek RP, Fearing CM, Pereira TA, et al:
Hedgehog-mediated epithelial-to-mesenchymal transition and
fibrogenic repair in nonalcoholic fatty liver disease.
Gastroenterology. 137:1478–1488.e8. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang X, Wang X, Lv Y, Xu L, Lin J and
Diao Y: Protection effect of kallistatin on carbon
tetrachloride-induced liver fibrosis in rats via antioxidative
stress. PLoS One. 9:e884982014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sahreen S, Khan MR and Khan RA: Evaluation
of Rumex hastatus leaves against hepatic fibrosis: A rat model. BMC
Complement Altern Med. 17:4352017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park EK, Jung HS, Yang HI, Yoo MC, Kim C
and Kim KS: Optimized THP-1 differentiation is required for the
detection of responses to weak stimuli. Inflamm Res. 56:45–50.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Prestigiacomo V, Weston A, Messner S,
Lampart F and Suter-Dick L: Pro-fibrotic compounds induce stellate
cell activation, ECM-remodelling and Nrf2 activation in a human
3D-multicellular model of liver fibrosis. PLoS One.
12:e01799952017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Knight V, Lourensz D, Tchongue J, Correia
J, Tipping P and Sievert W: Cytoplasmic domain of tissue factor
promotes liver fibrosis in mice. World J Gastroenterol.
23:5692–5699. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Buniatian G, Hamprecht B and Gebhardt R:
Glial fibrillary acidic protein as a marker of perisinusoidal
stellate cells that can distinguish between the normal and
myofibroblast-like phenotypes. Biol Cell. 87:65–73. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ismail MH and Pinzani M: Reversal of
hepatic fibrosis: Pathophysiological basis of antifibrotic
therapies. Hepat Med. 3:69–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang CY, Yuan WG, He P, Lei JH and Wang
CX: Liver fibrosis and hepatic stellate cells: Etiology,
pathological hallmarks and therapeutic targets. World J
Gastroenterol. 22:10512–10522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang XP, Ai WB, Wan LY, Zhang YQ and Wu
JF: The roles of microRNA families in hepatic fibrosis. Cell
Biosci. 7:342017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye Y, Li Z, Feng Q, Chen Z, Wu Z, Wang J,
Ye X, Zhang D, Liu L, Gao W, et al: Downregulation of microRNA-145
may contribute to liver fibrosis in biliary atresia by targeting
ADD3. PLoS One. 12:e01808962017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tu X, Zhang H and Zhang J, Zhao S, Zheng
X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y and Zhang J: MicroRNA-101
suppresses liver fibrosis by targeting the TGFβ signalling pathway.
J Pathol. 234:46–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Q, Qin CY, Zhao ZH, Fan YC and Wang
K: Epigenetic modifications in hepatic stellate cells contribute to
liver fibrosis. Tohoku J Exp Med. 229:35–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang JJ, Tao H and Li J: Hedgehog
signaling pathway as key player in liver fibrosis: New insights and
perspectives. Expert Opin Ther Targets. 18:1011–1021. 2014.
View Article : Google Scholar : PubMed/NCBI
|
